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Abstract
Malaria is caused by an obligate intracellular protozoan parasite that replicates within and
destroys erythrocytes. Asexual blood stages of the causative agent of the most virulent
form of human malaria, Plasmodium falciparum, can be cultivated indefinitely in vitro in
human erythrocytes, facilitating experimental analysis of parasite cell biology, biochemistry
and genetics. However, efforts to improve understanding of the basic biology of this impor-
tant pathogen and to develop urgently required new antimalarial drugs and vaccines, suffer
from a paucity of basic research tools. This includes a simple means of quantifying the
effects of drugs, antibodies and gene modifications on parasite fitness and replication rates.
Here we describe the development and validation of an extremely simple, robust plaque
assay that can be used to visualise parasite replication and resulting host erythrocyte
destruction at the level of clonal parasite populations. We demonstrate applications of the
plaque assay by using it for the phenotypic characterisation of two P. falciparum conditional
mutants displaying reduced fitness in vitro.
Introduction
As one of the most important human pathogens, much research on the human malaria parasite
Plasmodium falciparum focuses on the identification and characterisation of drug targets and/
or an improved understanding of how host immune responses interfere with parasite replica-
tion and associated pathology. During the clinically relevant asexual blood stage of the parasite
lifecycle, merozoites invade host erythrocytes where they divide within a parasitophorous vacu-
ole to produce 16–20 daughter merozoites. These are then released from the erythrocyte,
completely destroying it in the process. In certain regards the parasite blood-stage lifecycle
therefore mimics a viral lytic cycle, in that destruction of each host cell allows the release of
multiple invasive forms which go on to invade and destroy further host cells, amplifying the
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pathogen population. For many viruses, this lytic cell cycle has long been exploited in in vitro
assays in which the concentration of infectious viral particles in a sample can be determined by
microscopic visualisation of destruction of host cells following their infection by suitably
titrated aliquots of virus. First described for animal viruses by Dulbecco and Vogt in 1953 [1],
the assay protocol usually involves limiting diffusive dispersion of the released viral particles
through the use of semi-solid media in order to achieve discrete, highly localised regions of
host cell monolayer destruction called plaques. The cell monolayers are finally stained to visu-
alise the plaques. Because of their simplicity and broad applicability, plaque assays are amongst
the most valuable and widely-used tools in viral research, allowing facile quantitation of the
effects on viral replication of environmental conditions, drugs, antibodies and genetic manipu-
lation, and simplifying isolation of viral clones. Plaque assays have also been developed for
other intracellular pathogens, including several bacterial species [2] and even protozoan organ-
isms related to the malaria parasite, notably Toxoplasma gondii which readily infects most
nucleated mammalian cells and so can be cultured in adherent fibroblast monolayers [3]. In
contrast, blood stages of P. falciparum and other Plasmodium species pathogenic to humans
replicate exclusively in erythrocytes (or reticulocytes), which are not normally adherent. Plaque
assays developed for Plasmodium have therefore used monolayers of erythrocytes adhered to
the base of plastic tissue culture wells using concanavalin A [4, 5], Cell-Tak [6], or anti-Rhesus
D antibodies plus protein L [7], with plaque formation being visualised using either Giemsa
staining of fixed monolayers or immunofluorescence. Such assays were key to the success of
elegant pioneering experiments demonstrating the phenomenon in which all the merozoite off-
spring of a single infected erythrocyte are committed to either continuation of the asexual life
cycle or transformation into either male or female forms of the sexual stages (gametocytes)
responsible for transmission to the mosquito vector [4, 5, 7]. However, due to the single-cell-
thick nature of the adherent erythrocyte monolayers produced by these methods and the need
for fixation and staining to visualise the plaques, the assays are unsuitable for routine quantita-
tion of malaria parasite growth rates. Here we describe the optimisation and application of an
extremely simple plaque assay that we expect will become an attractive and widely used addi-
tion to the available repertoire of malaria research tools.
Results
P. falciparumGrowth in Static Erythrocyte Cultures Produces Plaques
In initial work, asexual blood-stage cultures of P. falciparum (clone 3D7) were dispensed in
complete medium into the central 60 wells of flat-bottomed 96-well microplates and incubated
undisturbed (without replacing the medium or disturbing the erythrocyte layers) at 37°C in
sealed, humidified gassed chambers, monitoring by daily examination with an inverted light
microscope. This revealed the gradual appearance and expansion of translucent, roughly circu-
lar discontinuities or apparent zones of clearance in the otherwise homogeneous erythrocyte
layer coating the base of each well (Fig 1A). These discontinuities are henceforth referred to as
plaques. Importantly, plaque formation was easily detected and recorded without opening the
plates using a high resolution flatbed digital scanner (top-down transmission light mode, 4,800
dpi), avoiding the need for frequent and laborious microscopic examination of individual wells
and also allowing simple recording and documentation of the plate images. To formally estab-
lish whether plaque formation was a result of parasite replication, synchronous parasite cul-
tures (~10% parasitaemia, 0.75% haematocrit) were serially diluted into a suspension of fresh
uninfected erythrocytes (0.75% haematocrit) in complete medium and aliquots of each dilution
dispensed across a microplate. Monitoring of plaque formation in these plates showed that the
mean frequency of plaques at any given dilution correlated linearly with the starting
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parasitaemia in each well (Fig 1B and 1C and S1 Fig). No plaques formed in the absence of par-
asites. These results suggested that, so long as the erythrocyte cultures remained static and
undisturbed, parasite growth with concomitant host cell lysis was capable of producing
restricted, microscopically discernible zones of erythrocyte destruction. The discrete nature of
the plaques was presumably a result of repeated cycles of preferential invasion and lysis of
immediately adjacent host cells upon completion of each erythrocytic growth cycle. To opti-
mise conditions for plaque formation and detection, further assays were performed using a
range of haematocrit values. This revealed that a haematocrit of 0.75% (~7.5 x 107 erythrocytes
per ml, or ~1.5 x 107 cells per well) resulted in optimal plaque morphology and clarity (Fig
1D). Interestingly, erythrocyte longevity under the conditions of the assay was also haemato-
crit-dependent, with clear signs of generalised erythrocyte lysis (i.e. appearance of free haemo-
globin in the medium) typically evident as early as 10 days at a 0.5% haematocrit, whilst at
higher haematocrits the cells were reproducibly completely stable for at least 2 weeks. All sub-
sequent work therefore used a haematocrit of 0.75%. Typically, plaques attained a maximum
diameter of ~0.1 mm before eventual complete lysis of all the erythrocytes between 16–21 days.
Note that this was not due to excessive parasitaemia in the microwell cultures; microscopic
examination of Giemsa-stained cultures recovered from wells containing 30 plaques at 14 days
revealed parasitaemia values of only ~0.06% (~1 parasite in 1600 erythrocytes examined).
Each P. falciparum-Infected Erythrocyte in the Starting Population
Forms One Plaque
We reasoned that during parasite growth in the environment of a microplate well, even under
the static conditions described above, diffusive movement of free merozoites or even infected
erythrocytes might allow multiple plaques to form from a single parental infected cell. To
investigate this possibility, a synchronous parasite culture at ring-stage was diluted into a sus-
pension of fresh erythrocytes at 0.75% haematocrit in order to obtain a theoretical density of
<5 parasitised erythrocytes per ml of culture. The suspension was dispensed into the central
wells of 4 flat-bottomed plates (200 μl/well, 240 wells total), then the resulting plaques enumer-
ated 15 days later. If the parasitised cells assort randomly and if each parasite-infected cell pro-
duces only a single discrete plaque, the numerical distribution of plaques across the wells is
expected to follow Poisson statistics. A key indicator of this is that the experimentally deter-
mined (observed) mean average number of plaques per well is sufficient to allow a prediction
Fig 1. Formation of plaques in static P. falciparum asexual blood stage microplate cultures. (A) Time-dependent
evolution of plaques. Scanned images (RGB) of a single microplate well (diameter 6.38 mm) taken at the indicated times
following the introduction of a low parasitaemia P. falciparum 3D7 culture (200 μl per well, 0.75% haematocrit, starting
parasitaemia ~0.00004%, corresponding to ~6 infected cells per well). Plaques first became detectable by light microscopy
or high resolution scanning at day 8. (B) Plaque density correlates with starting parasitaemia. Shown are microplate wells
containing 10-fold serial dilutions (indicated) of a P. falciparum culture (0.75% haematocrit, starting parasitaemia 13%). The
wells were imaged on day 13 following initiation of the culture. By this point, at the highest parasite densities (neat and 10−1
dilution) the erythrocyte layer was completely destroyed, whilst discrete plaques were visible at the lower parasite
densities. Total numbers of plaques in each set of 6 replicate wells of the 10−3–10−8 dilutions (replicate wells are not shown)
was 2,034 (10−3), 245 (10−4), 26 (10−5), 4 (10−6), and 0 plaques (10−7 and 10−8). No plaques were ever detected in the
complete absence of parasites (none). (C) Linear regression by analysis of covariance (ANCOVA) indicating a strong linear
inverse correlation between dilution and plaque density in the wells containing the 10−3–10−6 parasite dilutions. A plot of
observed mean plaque frequency against dilution (blue) from the experiment shown in (B) is shown alongside a plot of the
plaque frequencies expected if there is a linear inverse correlation between plaque number and dilution (red). Values of the
statistical data (R2, F statistic, number of degrees of freedom and p value) are shown. (D) Optimisation of haematocrit
conditions. Microplate wells containing cultures at ~0.00004% parasitaemia at the indicated haematocrits, imaged on day
15. Whilst plaque formation was easily detected in the 0.75% haematocrit wells, they were much more difficult to detect at
higher haematocrit, whilst at lower haematocrit values the plaques were typically more diffuse with signs of erythrocyte
lysis. Inset, zoomed region of the 0.75% haematocrit erythrocyte layer, showing the discrete nature of the plaques.
doi:10.1371/journal.pone.0157873.g001
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of the probability distribution of plaque numbers across all the wells. In the experiment
depicted in Table 1, the observed frequency distribution of plaques per well was compared to
the theoretical Poisson distribution with the same mean number of plaques per well as
observed in this experiment (0.388). A chi-squared test of goodness-of-fit showed that the
observed distribution of plaques per well was not significantly different from the expected Pois-
son distribution. Similar data were obtained from three additional independent plaque assays
with widely varying mean values of plaque numbers per well; in each case, the observed distri-
bution showed a good match with the expected Poisson distribution (S2 Fig). Together with
the observed linear relationship between plaque number and parasite dilution, these results
convincingly confirm that–at least under limiting dilution conditions where plaque numbers
can be accurately counted–each plaque usually or always derives from a single precursor para-
site-infected erythrocyte and multiple plaques do not frequently arise from a single infected
cell.
Use of the Plaque Assay for Phenotypic Analysis of a Replication-
Defective P. falciparumMutant
To explore the broader utility of the plaque assay, we applied it to the phenotypic characteriza-
tion of a genetically modified P. falciparum clone known to display a partially-defined growth
defect. Plasmodiummerozoites are uniformly coated with a glycolipid anchored surface protein
called MSP1. We have previously shown [8] that conditional genetic truncation of the P. falcip-
arumMSP1 gene to remove its C-terminal membrane-anchoring domain results in merozoites
that entirely lack surface-bound MSP1. These merozoites undergo highly inefficient egress
from the host erythrocyte, with a resulting defect in parasite replication under static conditions
in vitro. We predicted that this defect would manifest itself in the plaque assay as a reduction in
the number and/or size of plaques. To test this prediction, a culture of highly synchronized
ring-stage P. falciparumMSP1:loxPint parasites [8, 9], which possess a loxP-flanked 3’ segment
of theirMSP1 gene and constitutively express a rapamycin (RAP)-inducible form of Cre
recombinase (DiCre) [10], was divided into two. The cultures were then treated in parallel with
either RAP (to induce DiCre-mediated gene excision) or DMSO (control solvent) only. The
two treated cultures were washed, diluted identically to a theoretical ~75 parasitised cells per
ml (15 parasites/well, 0.75% haematocrit), dispensed into flat-bottomed microplates and the
Table 1. Poisson analysis of plaque formation shows that each plaque derives from a single parasite-
infected erythrocyte.
Plaque frequency
Plaques/well Observeda Expectedc
0 168 163
1 56b 63
2 11b 12
3 5b 2
aPlaque number in a total of 240 wells (4 microwell plates).
bThe total number of plaques in the four plates was 93, so the overall mean number of plaques/well (λ) is
given by 93/240 = 0.388.
cExpected values assuming a Poisson frequency distribution. A chi-squared goodness of ﬁt comparison of
the observed and expected data gave a value χ2 = 1.25 for 2 degrees of freedom, p>0.50, indicating no
signiﬁcant difference between the sets of values. Note that for the chi-squared calculations, data for the 2
plaques/well and 3 plaques/well were pooled in order to avoid using expected values of <5.
doi:10.1371/journal.pone.0157873.t001
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resulting plaques examined 14 days later. Imaged plaque numbers were determined by manual
counting, whilst the pixel area of individual plaques was quantified using the Magic Wand tool
of Adobe Photoshop CS5. As shown in Fig 2, plaques formed in the RAP-treated cultures were
smaller and less numerous (mean = 199.3, SD = 9.2, n = 54) than those formed in the control
wells (mean = 329.1, SD = 6.7, n = 205), with a two-tailed independent t-test revealing this dif-
ference to be highly significant (t = 9.290, d.f. = 257, p<0.0001). The differences in mean pla-
que area values indicate a fitness defect associated with truncation of MSP1, consistent with the
previously observed ~2-fold slower replication rate displayed by this mutant relative to the
parental parasite clone in standard parasite growth assays [8]. Collectively, these results show
that the plaque assay can be used as a simple means of rapidly characterizing even rather subtle
effects of mutagenesis on parasite fitness.
Rapid Phenotypic Analysis of a Conditional Lethal P. falciparumMutant
To further examine the applicability of the plaque assay, we used it to examine a second P. fal-
ciparummutant in which the DiCre system was used to conditionally disrupt a gene predicted
to be essential for in vitro growth. The malarial serine-rich antigen (SERA) family comprises a
group of papain-like proteins encoded by genes with variable numbers of orthologues in all
Plasmodium species examined [11]. Interest in the SERA proteins, which all share similarities
with papain-family proteases, has arisen from evidence that they play roles in parasite egress
and/or host cell invasion. Previous attempted direct gene disruption experiments using tar-
geted homologous recombination have suggested that two of the nine P. falciparum SERA
genes, SERA5 and SERA6, are essential in asexual blood stages [12, 13]. To extend our previous
work indicating that SERA6may have a function at egress [14], we produced transgenic P. fal-
ciparum parasites (called SERA6:loxP) in which the entire SERA6 locus was flanked by loxP
sites (manuscript in preparation; J. Thomas, C. Collins and M. Blackman). These parasites
were produced on the genetic background of the same DiCre-expressing parasite clone (called
1G5DC [10]) used to produce the MSP1:loxPint parasites described above. A synchronous cul-
ture of a SERA6:loxP clone was divided into two and treated in parallel with either RAP to
induce DiCre-mediated gene excision, or DMSO only. The treated cultures were washed,
diluted identically to a theoretical ~75 parasites per ml (15 parasites/well), dispensed into flat-
bottomed microplates and the resulting plaques imaged 14 days later. As shown in Fig 3A, the
results demonstrated a dramatic difference between the control DMSO-treated cultures, which
showed substantial numbers of plaques, and the RAP-treated parasites, in which only a single
plaque appeared in one well. RAP-mediated gene excision in the P. falciparum DiCre system,
whilst tightly regulated and highly efficient, is rarely complete in a treated population [8, 10].
This can result in heterogeneous parasite populations that contain both excised and non-
excised parasites, making it difficult to unambiguously assess the effects of gene modification
on parasite fitness in uncloned RAP-treated cultures. Based on the clear difference between the
RAP-treated and control SERA6:loxP parasites in the plaque assay, we hypothesized that the
single plaque formed in the RAP-treated cultures might be derived from a parasite that had not
undergone excision of the floxed SERA6 gene. To test this, parasites from the plaque-positive
well in the RAP-treated samples were expanded and analyzed by diagnostic PCR. This showed
that these parasites indeed possessed an intact, non-excised genomic SERA6 locus (Fig 3B).
These results convincingly demonstrate that loss of SERA6 expression produces non-viable
parasites that are completely unable to produce plaques. Importantly, because the plaque assay
allowed visualization of parasite fitness at the level of individual parasite clones, it enabled sim-
ple comparison of the RAP-treated and control cultures and allowed us to quickly demonstrate
Malaria Parasite Plaque Assay
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Fig 2. Phenotypic characterisation of an MSP1mutant using the plaque assay. Scatter plots showing
the distribution of plaque sizes obtained following treatment of MSP1:loxPint parasites with DMSO (control,
mock-treated) or RAP to induce DiCre-mediated truncation of MSP1. Plaque numbers (n = 205 for the
DMSO-treated samples and n = 54 for the RAP-treated samples) were counted manually. Plaque dimensions
were quantified using the Magic Wand tool of Photoshop CS5 (Adobe). Horizontal bars indicate mean plaque
area ± 1 SD.
doi:10.1371/journal.pone.0157873.g002
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Fig 3. Rapid phenotypic characterization of a lethal conditional P. falciparummutant using the plaque assay. (A) Left hand-
side; schematic of the results of plaque analysis of RAP-treated and DMSO (mock)-treated SERA6:loxP parasites. Microplate wells
coloured green indicate those that contained plaques 14 days following plating out the parasites at a theoretical 10 parasites/well.
White wells contained no plaques (wells shown in grey were not used for the cloning). Whereas plaques were present in every well of
the mock-treated culture, only a single plaque appeared in one well (well D8) of the RAP-treated culture. Right hand-side; example
wells from the RAP-treated and control plates (green channel only of the scanned image shown to enhance plaque visibility, displayed
as a grayscale image; see Materials and Methods for details). (B) Diagnostic PCR analysis of either the bulk SERA6:loxP parasite
population immediately following RAP or DMSO-treatment (before plaque assay), or parasites expanded from well D8 of the +RAP
plate. RAP-treatment significantly reduced the intact-SERA6 locus-specific signal in the parasite population and resulted in
appearance of a signal specific for the excised locus. Parasites rescued from well D8 of the RAP-treated parasites displayed a non-
excised genomic architecture. The results strongly suggest that excision of the SERA6 gene is lethal. Arrow-heads indicate the
oligonucleotide primers used for PR analysis: blue, SERA6-34; yellow, JTS5synthF; brown, JTPbDT3’R (see Materials and Methods
for primer sequences and PCR parameters). Expected sizes of the PCR amplicons are indicated.
doi:10.1371/journal.pone.0157873.g003
Malaria Parasite Plaque Assay
PLOS ONE | DOI:10.1371/journal.pone.0157873 June 22, 2016 8 / 14
that the only parasites in the RAP-treated population capable of surviving were those rare para-
sites in which excision of the SERA6 gene had not occurred.
Discussion
There has long been a need for a simple and robust plaque assay suitable for use with P. falcipa-
rum. Here we have developed such a system, using the simple expedient of culturing the para-
site under static, limiting dilution conditions in human erythrocytes in flat-bottomed
microplates. Visualisation of plaque formation was haematocrit-dependent, but we found that
plaques were easily detectable within ~2 weeks under optimised conditions (0.75% haemato-
crit). Based on a mean human erythrocyte volume of ~90 x 10−15 L [15], we calculate that
under the conditions used the settled erythrocytes formed layers that are at least 24 cells thick.
This likely allows productive parasite proliferation and plaque growth in 3 dimensions, as
opposed to the two dimensional plaque expansion allowed by the adherent erythrocyte mono-
layers used in previously-described P. falciparum plaque assays. The plaques, which presum-
ably comprise predominantly haemoglobin-free erythrocyte ghosts, cell debris and haemozoin
pigment, are completely stable under conditions of regular manual plate transferral to and
from incubators, even without the use of semi-solid media, probably because the small volumes
in each microplate well limit liquid movement and consequent disturbance of the erythrocyte
layer. Use of larger wells or flasks would probably destabilise plaques, which may explain why
the formation of these structures has not previously been described. Plaque integrity and stabil-
ity was further ensured in the assay by not replacing the medium during the 2–3 week period
of the assay. Although this may have the effect of limiting parasite growth rates, we found that
up to a plaque density of at least ~340 plaques per well, plaque frequency correlated with start-
ing parasite density, implying that—at least within this parasitaemia range—plaque formation
is not adversely affected by plaque density. Plaques produced by clonal parasite populations
were not completely homogeneous in size or shape, but this is a feature of many plaques,
including those produced by Toxoplasma. The P. falciparum plaques are easily visible using an
inverted light microscope and, similar to viral plaques [16], can be rapidly imaged with mini-
mal disturbance using an inexpensive, commercially available document scanner, avoiding the
need for laborious photographic imaging of individual wells. Indeed, using a high resolution
(4,800 dpi) flat-bed scanner in transmission light mode, we found that we were able to scan
and document up to 3 plates simultaneously in a single TIFF image, allowing for rapid docu-
mentation of multiple plates. The ready availability, low cost and lack of user training required
to use a flat-bed scanner makes this a highly accessible, medium-throughput means of docu-
menting the results of assays.
The P. falciparum plaque assay has important advantages compared to those commonly
used for viruses and other intracellular pathogens such as Toxoplasma. Mature erythrocytes do
not replicate, so there is no need to take into account changes in host cell confluency over the
course of the assay. Furthermore, there is no requirement to fix and stain the cells before plaque
analysis. The ability to easily visualise parasite clonal growth has other advantages. In our labo-
ratory we now regularly use the approach for rapid limiting dilution cloning of P. falciparum
lines without the need for laborious determination of starting parasitaemia values, simply by
performing serial dilutions of a parasite culture across a plate then picking clones only from
those wells that contain a single plaque. It is important to transfer these clones from the plaque
assay plates into cultures containing fresh erythrocytes before the plaque assay cultures begin
to undergo generalised erythrocyte lysis, which we found usually occurs between 16–21 days
after initiating the plaque assay. The plaque assay may be applicable to the study of other Plas-
modium species that can be cultivated in vitro, though our attempts to optimise it for use with
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culture-adapted lines of P. knowlesi [17] were not encouraging; in this case the plaques formed
were irregular and indistinct, perhaps a result of the well-documented greater extracellular
motility and longevity of free P. knowlesimerozoites [18, 19] which may allow more rapid dis-
persal of released merozoites within the wells than occurs with P. falciparum (unpublished
data, J. Thomas).
Reverse genetic technologies have become increasingly important in malarial research over
the past 2 decades. With the relatively recent introduction of Cas9-mediated mutagenesis [20,
21] and conditional gene modification technologies in P. falciparum [10, 22–24] we believe that
the development of simple assays such as that described here is particularly timely. The plaque
assay has multiple applications; here we have shown that it can be used to rapidly phenotype
genetic mutants without the need for complex equipment or facilities (e.g. flow cytometry or
spectrophotometry), but it also will be invaluable for the calculation of kill-curves with anti-para-
site drugs and antibodies, for the selection of drug-resistant or fast-growing mutants, for facile
comparison of parasite fitness under a range of growth conditions (e.g. in different defined
media) and numerous other uses. Differences in parasite growth rate are presumably propagated
over the course of the 4–7 cycles required to produce visible plaques, providing some advantages
over traditional growth assays in that the cultures do not need to be passaged or fed. Importantly,
the assay complements other widely used approaches for quantitation of parasite growth, includ-
ing light microscopy, flow cytometry and assays based on expression of parasite proteins or
enzymes [25, 26], incorporation of fluorescent dyes [27, 28] or radioactive hypoxanthine [29].
Although not explored here, the assay may be suitable for scaling up to high throughput image-
based screens using high content microscopy. We believe the plaque assay will prove a valuable
addition to the experimental tools available for studying this important pathogen.
Materials and Methods
P. falciparumMaintenance and Manipulation
Parasites (wild type clone 3D7, the DiCre-expressing clone 1G5DC [10], and MSP1:loxPint or
SERA6:loxP parasites which were produced on the 1G5DC genetic background [8, 9]) were
routinely cultured at 37°C in human erythrocytes at 1–4% haematocrit in RPMI 1640 (Life
Technologies) supplemented with 2.3 gL-1 sodium bicarbonate, 4 gL-1 dextrose, 5.957 gL-1
HEPES, 0.05 gL-1 hypoxanthine, 0.5% (w/v) Albumax II, 0.025 gL-1 gentamycin sulphate, and
0.292 gL-1 L-glutamine (complete medium) in a low oxygen atmosphere as previously
described [30, 31]. Parasitaemia was never allowed to exceed 10%. Human blood was obtained
from anonymised donors through the UK National Blood Transfusion service and was used
within 2 weeks of receipt. No ethical approval is required for its use. Routine microscopic
examination of parasite growth was performed by fixing air-dried thin blood films with 100%
methanol before staining with 10% Giemsa stain (VWR international) in 6.7 mM phosphate
buffer, pH 7.1. For routine microscopic determination of parasitaemia values, at least 5,000
erythrocytes were examined. Haematocrit values were determined using a haemocytometer
(Marienfield; 0.1 mm depth and 0.0025 mm2 area), assuming that 100% haematocrit equates to
1 x 1010 normocytes ml-1. For synchronisation, mature schizont stage parasites were isolated
on cushions of 70% (v/v) Percoll (GE Healthcare) adjusted to isotonicity as described [32, 33].
Lysis of mature forms of the parasite to enrich for ring forms after invasion was performed by
suspending parasites in 5% (w/v) D-sorbitol [32, 34].
Generation of Transgenic P. falciparum Clones and PCR Analysis
Production of the P. falciparumMSP1:loxPint clone which possess a loxP-flanked 3’ segment
of theMSP1 gene and constitutively expresses a RAP-inducible form of Cre recombinase has
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been described [8, 9]. Production of the SERA6:loxP line was achieved by introducing a loxP
site into the genome directly downstream of the SERA6 locus in the 1G5DC clone, which
already possesses a genomic loxP site downstream of the SERA5 locus. Details of the approach
used to generate the SERA6:loxP parasites will be provided separately (manuscript in prepara-
tion; J. Thomas, C. Collins and M. Blackman). When desired, transgenic parasites were treated
with RAP (100 nM final concentration) or DMSO (control vehicle, 1% v/v) for 4 h, as described
[10]. Genomic DNA was prepared from treated parasites for diagnostic PCR analysis as
described [10]. The intact modified SERA6 locus was amplified by PCR using oligonucleotide
primers JTPbDT3’R (5’-TTACAGTTATAAATACAATCAATTGG-3’) plus SERA6-34 (5’- GT
CCTGGAAGAAGAACGTTGCCGCCGCGAGACACAACACTGACTTCATG-3’). The
excised locus (following DiCre-mediated recombination) was amplified using primers
JTPbDT3’R plus JTS5synthF (5’- GAATGCTATTTCTGCTACGTG-3’). For diagnostic PCR
analysis a Kappa2G Fast HotStart ReadyMix PCR Kit (Kappa Biosystems) was used. Thermal
cycle conditions for amplification of the intact modified SERA6 locus were: initial denaturation
at 95°C for 60 sec, followed by 20 cycles of 95°C for 10 sec, 51°C for 10 sec and 72°C for 15 sec,
with a final extension at 72°C for 60 sec. Thermal cycle conditions for amplification of the
excised locus were: initial denaturation at 95°C for 60 sec, followed by 25 cycles of 95°C for
10 sec, 55°C for 10 sec and 72°C for 15 sec, with a final extension at 72°C for 60 sec.
Imaging, Documentation and Quantitation of Plaque Formation
To allow plaque formation, synchronous parasite cultures at ring stage were diluted to the
desired densities in complete medium with human erythrocytes at haematocrits between 0.5%
and 2%, then dispensed into flat-bottomed 96 well microplates (Costar 3596, Corning NY,
USA; 0.32 cm2 growth area per well, diameter 6.38 mm) using 200 μl culture per well. Plates
were incubated in gassed, humidified sealed modular incubator chambers (Billups-Rothenberg,
CA, USA). To limit evaporation, only the inner 60 wells of microplates were used for cultures
whilst sterile phosphate buffered saline was added to the outer wells of plates. Plaque formation
was assessed routinely by microscopic examination using a Nikon TMS inverted microscope
(40x magnification). When desired, plaque formation was documented without opening the
plates using a Perfection V750 Pro scanner (Epson) in top-down transmission light mode, sav-
ing images as 4,800 dpi RGB TIFF files. Usually 3 microplates were imaged simultaneously
with the scanner. Plaque visibility was generally enhanced by using the 'Split channels' function
of the Fiji distribution of ImageJ [35] to split the RGB TIFF file into red, green and blue data
channels, then using the green channel image for quantification of plaque dimensions, since
this provided maximum contrast between plaques and the surrounding erythrocyte layer. Pla-
ques were counted by visual examination of the images and plaque size quantified using the
Magic Wand tool in Adobe Photoshop CS5 using a tolerance setting value of 32. This tool
delineates the perimeter of selected plaques and calculates plaque area in pixels. No area value
was recorded for apparent plaques that could not be delineated by the tool. Statistical analysis
(linear regression analysis by analysis of covariance and t-test) was performed using GraphPad
Prism 7 software (CA, USA).
Supporting Information
S1 Fig. The experimentally observed frequency distribution of plaques in the plaque assay
follows a Poisson distribution.
(PDF)
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S2 Fig. Plaque frequency shows a linear correlation with parasite number.
(PDF)
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